CHRS Equity Ratio

Coherus Oncology Inc · Equity Ratio

CHRS logo

CHRS Equity Ratio

Current (TTM)31.82%
CHRS Equity Ratio (34.64% → 31.82%)
High-resolution chart · PNG

CHRS equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
23.6174%
-29.427%
-30.7217%
-28.5783%
14.3856%
33.3838%
25.7293%
-38.7978%
18.7779%
10.8435%
-3.2625%
35.6568%
-89.3249%
34.6437%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.